If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £44.46m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Exercise of Options & Director/PDMR Shareholding

20 Dec 2022 13:24

RNS Number : 3595K
Time Finance PLC
20 December 2022
 

20 December 2022

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Exercise of Employee Options and Director/PDMR Shareholdings

 

Time Finance plc, the AIM listed independent specialist finance provider, announces the exercise of share options ("Options") under the Company's Unapproved Share Option Scheme (the "Scheme").

 

The Option exercises, of nil cost Options under the Scheme by certain of the Company's directors and PDMRs, have been satisfied through the allocation of existing ordinary shares held by the Time Finance Employee Benefit Trust ("EBT") and, as such, no new ordinary shares have been issued in connection with the Option exercises.  Therefore, the total number of ordinary shares with voting rights in the Company following admission will remain 92,512,704. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Group under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules,

 

Of the aggregate of 178,500 ordinary shares allocated from the EBT in satisfying the Option exercises, 102,631 Ordinary Shares have been sold at a price of 21.2 pence per ordinary share to meet the tax liabilities arising from the exercises of Options, with the balance of Ordinary Shares from the exercises being retained by the participants in accordance with the terms of the Scheme.

 

Participant

Position

Ordinary Shares from

Option exercises

Ordinary

Shares disposed of

James Roberts

CFO

 123,500

48,413

Lorraine Neyland

PDMR

 31,000

10,608

Phil Chesham

PDMR

 24,000

9,848

 

As a result of the exercise of Options and taxation related disposal of New Ordinary Shares, James Roberts, the Company's Chief Financial Officer, is now interested in 524,086 ordinary shares, representing 0.6% of the Company's issued ordinary share capital.

 

The notifications below, provided in accordance with the requirements of the UK Market Abuse Regulation, provide further details.

 

For further information, please contact:

 

Time Finance plc

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

Cenkos Securities plc (NOMAD)

Ben Jeynes / Max Gould (Nomad)

Julian Morse (Sales)

0207 397 8900

Walbrook PR

0207 933 8780

Paul Vann / Joe Walker

07768 807631

paul.vann@walbrookpr.com

 

About Time Finance:

Time Finance's core strategy is to provide the finance UK SMEs require to fund their businesses. It offers a multi-product range for SMEs including asset, vehicle, loan and invoice finance. While focussed on being an 'own-book' lender the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. James Roberts

2. Lorraine Neyland

3. Phil Chesham

 

2

 

Reason for the notification

 

a)

 

Position/status

1. Chief Finance Officer

2. PDMR

3. PDMR

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Time Finance plc

b)

 

LEI

 

213800VG3QJGBP2MKR86

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

 

 

b)

 

Nature of the transaction

 

Exercise of nil cost share options under Unapproved Share Option Scheme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. Nil pence

2. Nil pence

3. Nil pence

 

1. 123,500

2. 31,000

3. 24,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - see table above

e)

 

Date of the transactions

 

19 December 2022

f)

 

Place of the transaction

Outside of a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. James Roberts

2. Lorraine Neyland

3. Phil Chesham

 

2

 

Reason for the notification

 

a)

 

Position/status

1. Chief Finance Officer

2. PDMR

3. PDMR

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Time Finance plc

b)

 

LEI

 

213800VG3QJGBP2MKR86

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

 

 

b)

 

Nature of the transaction

 

Sale of ordinary shares of 10p each pursuant to exercises of nil cost share options under Unapproved Share Option Scheme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. 21.2 pence

2. 21.2 pence

3. 21.2 pence

 

1. 48,413

2. 10,608

3. 9,848

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - see table above

e)

 

Date of the transactions

 

19 December 2022

f)

 

Place of the transaction

AIMX

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFVFILIFIF
Date   Source Headline
25th Jun 20267:00 amRNSTrading Update and Notice of Final Results
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.